Accrued Expenses

6 Months Ended

Jun. 30, 2022

Accrued Expenses

Accrued Expenses

Note 4. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	June 30,		December 31,
	2022		2021
Clinical trial expenses	$	2,019,712	$	2,625,779
Other		417,884		330,766
Total	$	2,437,596	$	2,956,545